The US Food and Drug Administration granted quick approval to produce two possible vaccines to counteract corona by BioNTech SE and Pfizer, which contributed to their stock increase in initial trading. / p>
According to ArabiaNet, BioNTech SE said in a tweet on Twitter, that it had obtained quick approval of two of the four properties it was developing to vaccinate against corona.
>In March, Pfizer entered into a partnership with BioNTech SE to develop and distribute anti-Corona vaccines. The value of the partnership is about 748 million dollars.
This comes at a time when a recent American study confirmed that tuberculosis vaccine can provide protection against coronavirus infection, especially as it is designed to protect against lung infections and enhance immunity. Against infection with infectious viruses.
A study conducted by researchers at the Virginia Institute of Applied Sciences and New York University revealed a clear link to the low death rate of corona virus in people who received the tuberculosis vaccine in various parts of the world. Countries of the World.
The scientists explained that the vaccine enhances the immune system in people, which makes it more effective and resistant to the symptoms of the epidemic, indicating that the tuberculosis vaccine can enhance the immunity gained in groups. Physically weak age, which reduces the severity of symptoms of coronavirus infection.
(Fun Knowledge of Knowledge)
